Computer-aided detection (CAD) firm Medipattern has completed a $3 million Canadian ($3 million U.S.) financing transaction.
Proceeds from the offering will be used to augment operating working capital and commercialize the company's Visualize:Vascular product, which received clearance from the U.S. Food and Drug Administration (FDA) in February, Medipattern said.